Perip7lakin is a target for autoimmunity in asthma

Respir Res. 2016 Oct 7;17(1):126. doi: 10.1186/s12931-016-0441-5.

Abstract

The role of autoimmunity targeting epithelial antigens in asthma has been suggested, in particular in non-atopic and severe asthma. Periplakin, a desmosomal component, is involved in epithelial cohesion and intracellular signaling. We detected anti-periplakin IgG antibodies in 47/260 (18 %) patients with asthma, with no association with severity or atopy. In addition, anti-periplakin IgE antibodies were detected in 12 of 138 tested patients (8.7 %) and were more frequently observed in patients with than without nasal polyposis. This study identifies a new autoimmune epithelial target in asthma. Whether periplakin autoimmunity (both IgG and IgE auto-antibodies) is involved in asthma pathogenesis remains to be studied during the disease course of these patients.

Keywords: Airway epithelium; Asthma; Autoimmunity; Desmosome; Nasal polyposis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asthma / blood
  • Asthma / diagnosis
  • Asthma / epidemiology
  • Asthma / immunology*
  • Autoantibodies / blood*
  • Autoimmunity*
  • Biomarkers / blood
  • Case-Control Studies
  • Female
  • France / epidemiology
  • Humans
  • Immunoglobulin E / blood*
  • Immunoglobulin G / blood*
  • Male
  • Middle Aged
  • Nasal Polyps / blood
  • Nasal Polyps / epidemiology
  • Nasal Polyps / immunology
  • Plakins / immunology*
  • Prevalence
  • Prospective Studies
  • Risk Factors
  • Seroepidemiologic Studies
  • Serologic Tests
  • Severity of Illness Index

Substances

  • Autoantibodies
  • Biomarkers
  • Immunoglobulin G
  • PPL protein, human
  • Plakins
  • Immunoglobulin E